Schnabl Kareena-L, Van Aerde John-E, Thomson Alan-Br, Clandinin Michael-T
Alberta Institute for Human Nutrition, 4-10 Ag/For Centre, University of Alberta, Edmonton, Alberta T6G 2P5, Canada.
World J Gastroenterol. 2008 Apr 14;14(14):2142-61. doi: 10.3748/wjg.14.2142.
Necrotizing enterocolitis is an inflammatory bowel disease of neonates with significant morbidity and mortality in preterm infants. Due to the multifactorial nature of the disease and limitations in disease models, early diagnosis remains challenging and the pathogenesis elusive. Although preterm birth, hypoxic-ischemic events, formula feeding, and abnormal bacteria colonization are established risk factors, the role of genetics and vasoactive/inflammatory mediators is unclear. Consequently, treatments do not target the specific underlying disease processes and are symptomatic and surgically invasive. Breast-feeding is the most effective preventative measure. Recent advances in the prevention of necrotizing enterocolitis have focused on bioactive nutrients and trophic factors in human milk. Development of new disease models including the aspect of prematurity that consistently predisposes neonates to the disease with multiple risk factors will improve our understanding of the pathogenesis and lead to discovery of innovative therapeutics.
坏死性小肠结肠炎是一种发生于新生儿的炎症性肠病,在早产儿中具有较高的发病率和死亡率。由于该疾病的多因素性质以及疾病模型的局限性,早期诊断仍然具有挑战性,其发病机制也尚不明确。尽管早产、缺氧缺血事件、配方奶喂养和异常细菌定植是已确定的危险因素,但遗传因素以及血管活性/炎症介质的作用尚不清楚。因此,治疗并非针对特定的潜在疾病过程,而是对症治疗且具有手术侵入性。母乳喂养是最有效的预防措施。坏死性小肠结肠炎预防方面的最新进展集中在人乳中的生物活性营养素和营养因子上。开发新的疾病模型,包括将早产这一始终使新生儿因多种危险因素而易患该疾病的因素纳入其中,将增进我们对发病机制的理解,并促使发现创新疗法。